Impact of changing open-label drug prescription policies on consent rates in a neonatal trial: a quasinatural experiment.

Storm KK, Flint RB, Onland W, Obermann-Borst SA, Poppe JA, Nuytemans DH, de Boode WP, Carkeek K, Cassart V, Cornette L, Dijk PH, Hemels MA, Hütten MC, Kelen D, de Kort EH, Kroon AA, Lefevere J, Plaskie K, Verbeeck S, Voeten M, Williams O, Zonnenberg IA, Te Pas AB, Reiss IK, van Kaam AH, Allegaert K, Smits A, Hutten GJ, Simons SH, DOXA-trial Consortium

Open source

DOI: 10.1136/archdischild-2026-330821
Published: 2026 Aug 10
Container: Archives of disease in childhood. Fetal and neonatal edition
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/archdischild-2026-330821,
  title = {Impact of changing open-label drug prescription policies on consent rates in a neonatal trial: a quasinatural experiment.},
  author = {Storm KK and Flint RB and Onland W and Obermann-Borst SA and Poppe JA and Nuytemans DH and de Boode WP and Carkeek K and Cassart V and Cornette L and Dijk PH and Hemels MA and Hütten MC and Kelen D and de Kort EH and Kroon AA and Lefevere J and Plaskie K and Verbeeck S and Voeten M and Williams O and Zonnenberg IA and Te Pas AB and Reiss IK and van Kaam AH and Allegaert K and Smits A and Hutten GJ and Simons SH and DOXA-trial Consortium},
  year = {2026},
  journal = {Archives of disease in childhood. Fetal and neonatal edition},
  doi = {10.1136/archdischild-2026-330821},
  url = {https://doi.org/10.1136/archdischild-2026-330821}
}

RIS

TY  - JOUR
TI  - Impact of changing open-label drug prescription policies on consent rates in a neonatal trial: a quasinatural experiment.
AU  - Storm KK
AU  - Flint RB
AU  - Onland W
AU  - Obermann-Borst SA
AU  - Poppe JA
AU  - Nuytemans DH
AU  - de Boode WP
AU  - Carkeek K
AU  - Cassart V
AU  - Cornette L
AU  - Dijk PH
AU  - Hemels MA
AU  - Hütten MC
AU  - Kelen D
AU  - de Kort EH
AU  - Kroon AA
AU  - Lefevere J
AU  - Plaskie K
AU  - Verbeeck S
AU  - Voeten M
AU  - Williams O
AU  - Zonnenberg IA
AU  - Te Pas AB
AU  - Reiss IK
AU  - van Kaam AH
AU  - Allegaert K
AU  - Smits A
AU  - Hutten GJ
AU  - Simons SH
AU  - DOXA-trial Consortium
PY  - 2026
JO  - Archives of disease in childhood. Fetal and neonatal edition
DO  - 10.1136/archdischild-2026-330821
UR  - https://doi.org/10.1136/archdischild-2026-330821
ER  -

APA

KK, S., RB, F., W, O., SA, O., JA, P., DH, N., WP, D. B., K, C., V, C., L, C., PH, D., MA, H., MC, H., D, K., EH, D. K., AA, K., J, L., K, P., S, V., M, V., O, W., IA, Z., AB, T. P., IK, R., AH, V. K., K, A., A, S., GJ, H., SH, S., & Consortium, D. (2026). Impact of changing open-label drug prescription policies on consent rates in a neonatal trial: a quasinatural experiment.. Archives of disease in childhood. Fetal and neonatal edition. https://doi.org/10.1136/archdischild-2026-330821

Source records

pubmed · retrieved 2026-09-26T05:33:51.272Z